Home
About
Investors
Science
Announcements

Announcements

Cardiogeni PLC – £20M MoU for Funding Clinical Development in UAE

Feb 10, 2025

Read More

Cardiogeni PLC – Admission on AQSE and First Day of Dealings

Jan 31, 2025

Read More

Cardiogeni is committed to advancing pioneering cellular therapies that repair and reactivate heart tissue leading to improved heart health. Guided by world-leading science, commercial excellence and a dedication to patient impact, we strive to deliver safe, effective, and life-changing solutions for those living with heart failure.

Navigation

Home
About
Investors
Science
Announcements

Socials

Address

Cardiogeni Plc
Celixir House,
Innovation Way,
Stratford-Upon-Avon,
England,
CV37 7GZ

© 2025 Cardiogeni. All rights reserved.

Terms and Conditions | Privacy Policy

Designed By: